Intermittent Fasting to Improve Insulin Secretion

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

April 8, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

March 1, 2025

Conditions
PreDiabetesDiabetes type2Intermittent FastingInsulin Secretion
Interventions
BEHAVIORAL

Intermittent fasting

The intermittent fasting intervention consists of a decreased daily caloric intake of 400 kcal below individual requirements (Harris Benedict Formula) combined with early time restricted fasting according to the schema 16:8. fasting will be performed over 4 weeks.

BEHAVIORAL

Control diet

Control group will be advised to reduce daily caloric intake of 400 kcal below individual requirements (Harris Benedict formula)

Trial Locations (8)

10117

NOT_YET_RECRUITING

Charité Berlin - Department of Endocrinology and Metabolic Diseases, Berlin

23538

NOT_YET_RECRUITING

University of Luebeck - Institute of Endocrinology and Diabetes, Lübeck

40225

NOT_YET_RECRUITING

German Diabetes Center, Düsseldorf

69120

NOT_YET_RECRUITING

Heidelberg University Hospital - Department of Endocrinology and Metabolism, Heidelberg

72076

RECRUITING

University Hospital Tuebingen - Institute for Diabetes Research and Metabolic Diseases (IDM), Tübingen

80992

NOT_YET_RECRUITING

Technical University of Munich - Else Kroener-Fresenius-Center for Nutritional Medicine, Munich

01307

NOT_YET_RECRUITING

Universtiy Hospital Carl Gustav Carus, Dresden

04103

NOT_YET_RECRUITING

University Hospital Leipzig - Clinic for Endocrinology and Nephrology, Leipzig

Sponsors
All Listed Sponsors
collaborator

German Institute of Human Nutrition

OTHER

collaborator

Charite University, Berlin, Germany

OTHER

collaborator

University Hospital Carl Gustav Carus

OTHER

collaborator

University of Leipzig

OTHER

collaborator

Ludwig-Maximilians - University of Munich

OTHER

collaborator

University Hospital Heidelberg

OTHER

collaborator

University of Luebeck

OTHER

collaborator

German Diabetes-Center, Leibniz-Institut in Düsseldorf

OTHER

collaborator

German Center for Diabetes Research

OTHER

lead

University Hospital Tuebingen

OTHER